You are here: Welcome » David Boulware

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision		Previous revision
Both sides next revision
david_boulware [2023/05/18 01:30]
liam [Career] 		david_boulware [2025/04/30 01:29] (current)
liam
Line 9: Line 9:
 ==== Education ==== ==== Education ====
  
-Boulware graduated from [[Wabash College]] in 1996 with a Bachelor of Arts in Chemistry.((//Dr. David Boulware ’96/King Distinguished Professor at UMN – Alumni News.// (2011, November 4). Wabash College. http://archive.today/2023.05.17-050444/https://blog.wabash.edu/alumninews/2011/11/04/dr-david-boulware-96king-distinguished-professor-at-umn/)) He later attended the [[Indiana University School of Medicine]], graduating in 2000.((Boulware, D. R. (2021). //Clinical & Translational Research in Cryptococcosis.// Mycoses Study Group Education & Research Consortium. https://web.archive.org/web/20230517231334/https://msgerc.org/resources/Documents/Boulware%20Slides_4.26.pdf)) He completed various residencies and fellowships from 2000-2007, receiving a certificate in tropical medicine from the [[Centers for Disease Control and Prevention]] (CDC) in 2006. He completed his Masters in Public Health in 2007.+Boulware graduated from [[Wabash College]] in 1996 with a Bachelor of Arts in Chemistry.((//Dr. David Boulware ’96/King Distinguished Professor at UMN – Alumni News.// (2011, November 4). Wabash College. http://archive.today/2023.05.17-050444/https://blog.wabash.edu/alumninews/2011/11/04/dr-david-boulware-96king-distinguished-professor-at-umn/)) He was a member of the [[Phi Kappa Psi]] fraternity.((Paige, R. (2020, April 2). //With a Gift for Science, Boulware ’96 Seeks Cure.// Wabash College. http://archive.today/2023.05.17-233333/https://www.wabash.edu/news/story/11580)) 
 + 
 +He later attended the [[Indiana University School of Medicine]], graduating in 2000.((Boulware, D. R. (2021). //Clinical & Translational Research in Cryptococcosis.// Mycoses Study Group Education & Research Consortium. https://web.archive.org/web/20230517231334/https://msgerc.org/resources/Documents/Boulware%20Slides_4.26.pdf)) He completed various residencies and fellowships from 2000-2007, receiving a certificate in tropical medicine from the [[Centers for Disease Control and Prevention]] (CDC) in 2006. He completed his Masters in Public Health in 2007.
  
 ==== Career ==== ==== Career ====
Line 36: Line 38:
 On June 3, 2020, the results of Boulware's trial were published in the //[[New England Journal of Medicine]]// (NEJM), finding that "hydroxychloroquine did not prevent illness compatible with [[Covid-19]] or confirmed infection when used as postexposure prophylaxis within 4 days after exposure."((Boulware, D. R., Pullen, M. F., Bangdiwala, A. S., Pastick, K. A., Lofgren, S. M., Okafor, E. C., Skipper, C. P., Nascene, A. A., Nicol, M. R., Abassi, M., Engen, N. W., Cheng, M. P., LaBar, D., Lother, S. A., MacKenzie, L. J., Drobot, G., Marten, N., Zarychanski, R., Kelly, L. E., & Schwartz, I. S. (2020). //A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.// New England Journal of Medicine, 383(6). https://doi.org/10.1056/nejmoa2016638)) On June 3, 2020, the results of Boulware's trial were published in the //[[New England Journal of Medicine]]// (NEJM), finding that "hydroxychloroquine did not prevent illness compatible with [[Covid-19]] or confirmed infection when used as postexposure prophylaxis within 4 days after exposure."((Boulware, D. R., Pullen, M. F., Bangdiwala, A. S., Pastick, K. A., Lofgren, S. M., Okafor, E. C., Skipper, C. P., Nascene, A. A., Nicol, M. R., Abassi, M., Engen, N. W., Cheng, M. P., LaBar, D., Lother, S. A., MacKenzie, L. J., Drobot, G., Marten, N., Zarychanski, R., Kelly, L. E., & Schwartz, I. S. (2020). //A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.// New England Journal of Medicine, 383(6). https://doi.org/10.1056/nejmoa2016638))
  
 +Later in June, Boulware provided commentary to the press about the price of [[remdesivir]], saying that "from the health system perspective, if remdesivir can shorten duration of hospitalization by four days, then the medicine provides a reasonable value."((//Drug company to charge thousands for coronavirus treatment.// (2020, June 29). NBC News; Associated Press. http://archive.today/2020.06.29-144326/https://www.nbcnews.com/health/health-news/remdesivir-coronavirus-gilead-charge-thousands-treatment-u-s-n1232385))
 ===== Activities ===== ===== Activities =====
  
Line 46: Line 49:
   * [[Doris Duke Charitable Foundation]]   * [[Doris Duke Charitable Foundation]]
   * [[Fogarty International Center]] (FIC)   * [[Fogarty International Center]] (FIC)
 +  * [[pharmaceutical_companies:Gilead Sciences]]((MSGERC Headquarters. (2018, October 25). //MSGERC 2018: Cryptococcus: David Boulware.// YouTube. https://web.archive.org/web/20230518194253/https://www.youtube.com/watch?v=QnQ1k4YcCWM))
   * [[pharmaceutical_companies:GlaxoSmithKline]]   * [[pharmaceutical_companies:GlaxoSmithKline]]
   * [[Hennepin Healthcare Research Institute]]   * [[Hennepin Healthcare Research Institute]]
Line 58: Line 62:
   * [[University of Virginia]]   * [[University of Virginia]]
  
 +He has additionally acted as an advisor to [[pharmaceutical_companies:Viamet]] and [[medical_technology_companies:Minnetronix]].((MSGERC Headquarters. (2018, October 25). //MSGERC 2018: Cryptococcus: David Boulware.// YouTube. https://web.archive.org/web/20230518194253/https://www.youtube.com/watch?v=QnQ1k4YcCWM))
 ===== External links ===== ===== External links =====
  
   * [[https://www.linkedin.com/in/davidboulware/|LinkedIn]]   * [[https://www.linkedin.com/in/davidboulware/|LinkedIn]]
 +  * [[https://www.whiteroseintelligence.com/david-boulware/|White Rose Wiki]]
   * [[https://en.wikipedia.org/wiki/David_Boulware|Wikipedia]]   * [[https://en.wikipedia.org/wiki/David_Boulware|Wikipedia]]
Back to top